Silke Wiedmann1, Steffi Hillmann2, Sònia Abilleira2, Martin Dennis2, Peter Hermanek2, Maciej Niewada2, Bo Norrving2, Kjell Asplund2, Anthony G Rudd2, Charles D A Wolfe2, Peter U Heuschmann2. 1. From the Institute of Clinical Epidemiology and Biometry (S.W., S.H., P.U.H.), Comprehensive Heart Failure Centre (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Stroke Programme/Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain (S.A.); Department of Clinical Neurosciences, Western General Hospital, Edinburgh, United Kingdom (M.D.); Bavarian Permanent Working Party for Quality Assurance, Munich, Germany (P.H.); Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland (M.N.); Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden (B.N.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); and Division of Health and Social Care Research (A.G.R.) and National Institute for Health Research Biomedical Research Centre Guy's & St Thomas' NHS Foundation Trust (C.D.A.W.), King's College London, London, United Kingdom. silke.wiedmann@uni-wuerzburg.de. 2. From the Institute of Clinical Epidemiology and Biometry (S.W., S.H., P.U.H.), Comprehensive Heart Failure Centre (S.W., P.U.H.), University of Würzburg, Würzburg, Germany; Stroke Programme/Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain (S.A.); Department of Clinical Neurosciences, Western General Hospital, Edinburgh, United Kingdom (M.D.); Bavarian Permanent Working Party for Quality Assurance, Munich, Germany (P.H.); Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland (M.N.); Department of Clinical Sciences, Neurology, Lund University, Lund, Sweden (B.N.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (K.A.); and Division of Health and Social Care Research (A.G.R.) and National Institute for Health Research Biomedical Research Centre Guy's & St Thomas' NHS Foundation Trust (C.D.A.W.), King's College London, London, United Kingdom.
Abstract
BACKGROUND AND PURPOSE: We compared compliance with standards of acute stroke care between 6 European audits and identified factors associated with delivery of appropriate care. METHODS: Data were derived from stroke audits in Germany, Poland, Scotland, Catalonia, Sweden, and England/Wales/Northern-Ireland participating within the European Implementation Score (EIS) collaboration. Associations between demographic and clinical characteristics with adherence to predefined quality indicators were investigated by hierarchical logistic regression analyses. RESULTS: In 2007/2008 data from 329 122 patients with stroke were documented. Substantial variations in adherence to quality indicators were found; older age was associated with a lower probability of receiving thrombolytic therapy, anticoagulant therapy, or stroke unit treatment and a higher probability of being tested for dysphagia. Women were less likely to receive anticoagulant or antiplatelet therapy or stroke unit treatment. No major weekend effect was found. CONCLUSIONS: Detected variations in performance of acute stroke services were found. Differences in adherence to quality indicators might indicate population subgroups with specific needs for improving care delivery.
BACKGROUND AND PURPOSE: We compared compliance with standards of acute stroke care between 6 European audits and identified factors associated with delivery of appropriate care. METHODS: Data were derived from stroke audits in Germany, Poland, Scotland, Catalonia, Sweden, and England/Wales/Northern-Ireland participating within the European Implementation Score (EIS) collaboration. Associations between demographic and clinical characteristics with adherence to predefined quality indicators were investigated by hierarchical logistic regression analyses. RESULTS: In 2007/2008 data from 329 122 patients with stroke were documented. Substantial variations in adherence to quality indicators were found; older age was associated with a lower probability of receiving thrombolytic therapy, anticoagulant therapy, or stroke unit treatment and a higher probability of being tested for dysphagia. Women were less likely to receive anticoagulant or antiplatelet therapy or stroke unit treatment. No major weekend effect was found. CONCLUSIONS: Detected variations in performance of acute stroke services were found. Differences in adherence to quality indicators might indicate population subgroups with specific needs for improving care delivery.
Authors: Deborah A Levine; Anthony J Perkins; Jason J Sico; Laura J Myers; Michael S Phipps; Ying Zhang; Dawn M Bravata Journal: Stroke Date: 2021-05-27 Impact factor: 10.170
Authors: Javier Mar; Jaime Masjuan; Juan Oliva-Moreno; Nuria Gonzalez-Rojas; Virginia Becerra; Miguel Ángel Casado; Covadonga Torres; María Yebenes; Manuel Quintana; Jose Alvarez-Sabín Journal: Health Qual Life Outcomes Date: 2015-03-17 Impact factor: 3.186
Authors: Steffi Hillmann; Silke Wiedmann; Alec Fraser; Juan Baeza; Anthony Rudd; Bo Norrving; Kjell Asplund; Maciej Niewada; Martin Dennis; Peter Hermanek; Charles D A Wolfe; Peter U Heuschmann Journal: Biomed Res Int Date: 2015-12-09 Impact factor: 3.411
Authors: Stephen Morris; Angus I G Ramsay; Ruth J Boaden; Rachael M Hunter; Christopher McKevitt; Lizz Paley; Catherine Perry; Anthony G Rudd; Simon J Turner; Pippa J Tyrrell; Charles D A Wolfe; Naomi J Fulop Journal: BMJ Date: 2019-01-23